Company Overview and News
U.S. equities surged higher on Tuesday, aided by a positive outlook from Adobe (NASDAQ:ADBE) overnight. Traders focused in on extremely strong jobs data, with the JOLTS report showing more than seven million openings for the first time ever. Moreover, there are now more than a million more job openings than unemployed persons.
HMY AULGF EAT SJM TWTR AU AGG HGMCF ADBE
VANCOUVER, BC / ACCESSWIRE / October 17, 2018 / Renaissance Gold Inc. (TSX.V: REN / OTCQB: RNSGF) ("RenGold" or the "Company") is pleased to report on the progress and status of its Nevada, USA projects and our anticipated drilling plans for the remainder of 2018. The location of RenGold's properties is shown in Figure 1.
AULGF RNSGF RMS REN RDUFF AU AGG S2R RDU RMLRF
As of late, it has definitely been a great time to be an investor in AngloGold Ashanti Limited (AU - Free Report) . The stock has moved higher by 20.9% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.
AULGF AU AGG
BOGOTA, Oct 11 (Reuters) - Colombia’s constitutional court on Thursday ruled that local referendums that ban mining and oil extraction cannot halt energy projects, after a raft of votes spooked multinational companies.
AULGF AU AGG
Franco-Nevada Corporation (FNV - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $61.49 to $65.29 in the past one-month time frame. The company has seen one negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road.
AULGF AU AGG FNV
BOGOTA (Reuters) - Colombia’s constitutional court on Thursday ruled that local referendums that ban mining and oil extraction cannot halt energy projects, after a raft of votes spooked multinational companies.
AULGF AU AGG
BAMAKO, Oct 5 (Reuters) - Industrial gold production in Mali, Africa’s third biggest producer, is still expected to rise almost 21 percent to 60 tonnes this year, a government official told Reuters on Friday, despite slightly lower than expected output so far.
AULGF RSG RMGGY HUMRF RGORF RMGGF AU AGG GOLD RRS HUM GOLD
DAKAR (Reuters) - Randgold Resources Ltd has run into opposition from the Democratic Republic of Congo’s government, which is insisting that it authorize the acquisition by Canada’s Barrick Gold Corp of Randgold’s stake in a Congolese gold mine.
AULGF ABX RGORF AU 3993 AGG GOLD RRS GOLD ABX
DAKAR, Sept 28 (Reuters) - Barrick Gold Corp’s acquisition of Randgold’s stake in the Kibali gold mine requires approval by the Democratic Republic of Congo’s government, Mines Minister Martin Kabwelulu said on Friday.
AULGF ABX AU AGG ABX
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
as of ET